Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofIdarubicin Hydrochloride for Injectionfrom Surat, Gujarat, India. Idarubicin Hydrochloride for Injection used for treatment of acute lymphoblastic leukemia and chronic myelogenous leukemia in blast crisis.
Tags: Idarubicin Hydrochloride for Injection manufacturer, Idarubicin Hydrochloridefor Injection exporter, Idarubicin Hydrochloride for Injection supplier,and Idarubicin Hydrochloride for Injection, whogmp approved Idarubicin Hydrochloridefor Injection manufacturer and supplier, Idarubicin Hydrochloride ForInjection distributor, Idarubicin Hydrochloride for Injection shipper, Idarubicin Hydrochloridefor Injection 5 ml Idarubicin Hydrochloride for Injection 5 mlsupplier,Idarubicin Hydrochloride for Injection 5 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy Lifescience Idarubicin Hydrochloridefor Injection export to USA, Canada, Germany, Europe, France,Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon,Peru, Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore,Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau,Congo, Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua,Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine,Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan,Kazakhstan.
Purpose and IndicationIdarubicin Hydrochloride for Injection is specifically formulated for the management of acute myeloid leukemia (AML) and select other hematological cancers. Its efficacy stems from its ability to inhibit cancer cell proliferation. For best outcomes, the therapy should only be administered under the guidance of qualified healthcare providers.
Correct Preparation and AdministrationThis medication is supplied as a lyophilized powder in USP-compliant glass vials and requires careful reconstitution with either 0.9% Sodium Chloride Injection or Sterile Water for Injection. Administration is through intravenous infusion only. The reconstituted solution should be stored at 2-8C and used within 24 hours for optimal stability.
Safety and Handling PrecautionsAs a cytotoxic agent, Idarubicin Hydrochloride demands strict handling procedures to ensure safety. Use personal protective equipment, avoid contact with skin and eyes, and handle under specialized conditions. It should never be used in patients with known hypersensitivity to anthracyclines or those with severe cardiac impairment.
FAQ's of Idarubicin Hydrochloride for Injection:
Q: How should Idarubicin Hydrochloride for Injection be reconstituted and administered?
A: Idarubicin Hydrochloride should be reconstituted using 0.9% Sodium Chloride Injection or Sterile Water for Injection. Once dissolved, the solution is administered through intravenous infusion by a healthcare professional. Adherence to aseptic techniques is crucial to ensure patient safety.
Q: What illnesses is Idarubicin Hydrochloride indicated to treat?
A: This medicine is indicated primarily for the treatment of acute myeloid leukemia (AML) and certain other hematological malignancies. It is not intended for conditions outside these indications and should be prescribed only by oncology specialists.
Q: When should the reconstituted solution of Idarubicin be used after preparation?
A: The reconstituted solution remains stable for up to 24 hours when stored at 2-8C. It should be used within this time window to maintain efficacy and safety. After 24 hours, any unused solution must be discarded.
Q: Where should Idarubicin Hydrochloride for Injection be stored before and after reconstitution?
A: Before reconstitution, store the lyophilized powder vials in a cool, dry place. After preparation, the reconstituted solution should be kept refrigerated at 2-8C and used within 24 hours.
Q: What processes and precautions must be followed when handling this cytotoxic agent?
A: Idarubicin Hydrochloride must be handled using appropriate cytotoxic precautions. This includes wearing gloves, gowns, and eye protection, as well as using designated workspaces. Avoid inhalation or direct contact with the skin and eyes.
Q: What are the main benefits of using Idarubicin Hydrochloride in cancer treatment?
A: Idarubicin Hydrochloride is effective in inhibiting the growth of malignant cells in patients with AML and other blood cancers, thereby improving treatment outcomes under controlled medical supervision.
Q: Is it normal for the reconstituted solution to have a fermentation smell, and what is its pH level?
A: Yes, a fermentation smell is expected and normal for Idarubicin Hydrochloride for Injection. The reconstituted solution has an approximate pH of 3.0.